Shanghai RAAS Blood Products Co Ltd Class A Working Capital to Net Assets Ratio

Latest as of June 2026: 25.4%

Shanghai RAAS Blood Products Co Ltd Class A working capital to net assets ratio. Shanghai RAAS Blood Products Co Ltd Class A (002252) has a Working Capital to Net Assets ratio of 25.4% as of June 2026. Working capital of CN¥8.24 Billion (current assets of CN¥10.60 Billion minus current liabilities of CN¥2.36 Billion) is measured against net assets of CN¥32.41 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.

WC/NA Ratio

25.4%
Working Capital / Net Assets

Working Capital

CN¥8.24 Billion
CNY

Current Assets

CN¥10.60 Billion
CNY

Current Liabilities

CN¥2.36 Billion
CNY

Working Capital to Net Assets Ratio of Shanghai RAAS Blood Products Co Ltd Class A (2005–2025)

Working capital to net assets ratio of Shanghai RAAS Blood Products Co Ltd Class A from 2005 to 2025. This chart shows how Shanghai RAAS Blood Products Co Ltd Class A's Working Capital to Net Assets ratio has evolved across 21 annual periods from 2005 to 2025. As of June 2026, the ratio stands at 25.4%, reflecting working capital of CN¥8.24 Billion against net assets of CN¥32.41 Billion CNY. See 002252 days of operational coverage to measure how many days the company can operate on defensive assets alone.

Shanghai RAAS Blood Products Co Ltd Class A Working Capital to Net Assets Ratio by Year (2005–2025)

Shanghai RAAS Blood Products Co Ltd Class A working capital to net assets ratio by year from 2005 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Shanghai RAAS Blood Products Co Ltd Class A from 2005 to 2025, covering 21 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 002252 current and non-current assets.

Year WC/NA Ratio Working Capital (CNY) Net Assets Current Assets Current Liabilities Change (pp)
2025 22.2% CN¥7.21 Billion CN¥32.47 Billion CN¥9.95 Billion CN¥2.74 Billion ▼ -1.6 pp
2024 23.8% CN¥7.61 Billion CN¥31.94 Billion CN¥9.26 Billion CN¥1.65 Billion ▲ +2.1 pp
2023 21.7% CN¥6.43 Billion CN¥29.65 Billion CN¥8.68 Billion CN¥2.24 Billion ▼ -2.1 pp
2022 23.8% CN¥6.85 Billion CN¥28.81 Billion CN¥8.47 Billion CN¥1.62 Billion ▲ +2.3 pp
2021 21.5% CN¥5.57 Billion CN¥25.90 Billion CN¥6.87 Billion CN¥1.31 Billion ▲ +2.9 pp
2020 18.6% CN¥4.68 Billion CN¥25.13 Billion CN¥5.01 Billion CN¥330.24 Million ▼ -18.1 pp
2019 36.7% CN¥4.22 Billion CN¥11.49 Billion CN¥4.53 Billion CN¥309.40 Million ▲ +4.7 pp
2018 32.0% CN¥3.49 Billion CN¥10.90 Billion CN¥3.91 Billion CN¥424.60 Million ▼ -18.3 pp
2017 50.3% CN¥6.27 Billion CN¥12.48 Billion CN¥6.94 Billion CN¥663.86 Million ▲ +5.9 pp
2016 44.3% CN¥5.20 Billion CN¥11.73 Billion CN¥6.07 Billion CN¥871.32 Million ▲ +1.8 pp
2015 42.6% CN¥4.56 Billion CN¥10.71 Billion CN¥4.81 Billion CN¥246.99 Million ▲ +15.4 pp
2014 27.2% CN¥2.34 Billion CN¥8.62 Billion CN¥2.67 Billion CN¥324.71 Million ▼ -46.0 pp
2013 73.2% CN¥806.33 Million CN¥1.10 Billion CN¥896.48 Million CN¥90.15 Million ▲ +25.2 pp
2012 47.9% CN¥488.73 Million CN¥1.02 Billion CN¥650.17 Million CN¥161.44 Million ▼ -10.8 pp
2011 58.7% CN¥544.65 Million CN¥927.27 Million CN¥614.00 Million CN¥69.35 Million ▼ -11.8 pp
2010 70.6% CN¥586.61 Million CN¥831.21 Million CN¥674.23 Million CN¥87.62 Million ▼ -9.6 pp
2009 80.2% CN¥611.85 Million CN¥763.33 Million CN¥663.73 Million CN¥51.88 Million ▼ -4.5 pp
2008 84.7% CN¥639.22 Million CN¥754.76 Million CN¥715.65 Million CN¥76.42 Million ▲ +47.4 pp
2007 37.2% CN¥63.32 Million CN¥170.01 Million CN¥199.85 Million CN¥136.53 Million ▼ -2.4 pp
2006 39.6% CN¥62.12 Million CN¥156.77 Million CN¥230.51 Million CN¥168.39 Million ▼ -22.6 pp
2005 62.3% CN¥144.25 Million CN¥231.70 Million CN¥246.18 Million CN¥101.93 Million —
pp = percentage points